The Schrödinger Boston User Meeting will be held at the Museum of Science on June 5, preceding the CHI Structure-Based Drug Design conference. As in past years, the regional user meetings offer a great opportunity to see current research from your colleagues and to learn about the latest developments from Schrödinger.

Agenda

  8:30       Breakfast & registration
  9:00       TBD
                 Roy Vaz, Senior Director, Sanofi
  9:40       Rapid drug discovery at Nimbus and the role of Seurat
                 Matt Wessel, Senior Principal Scientist, Schrödinger
10:20       Coffee break
10:50       Large protein-interaction data sets and strategies for modeling binding specificity
                 Amy Keating, Associate Professor, MIT
11:35       Introducing BioLuminate: A program for the design of bio-pharmaceuticals
                 Dave Pearlman, Senior Principal Scientist, Schrödinger
12:20       Lunch break
  1:30       The many contributions to protein-ligand binding: Implications in drug design
                 Cristiano Guimarães, Senior Principal Scientist, Pfizer
  2:10       PyMOL v1.5: New features and recent developments
                 Jason Vertrees, Principal Scientist, Schrödinger
  2:40       Schrödinger’s virtual screening study on Cycle Computing’s 50K-core utility
                 supercomputer on AWS cloud
                 Alessandro Monge, Vice President of Business Development, Schrödinger
  3:00       Schrödinger Suite 2012: New features, products, and enhancements
                 Woody Sherman, Vice President of Applications Science, Schrödinger 
  3:30       Reception at Schrödinger Cambridge office

Registration

This meeting is offered free of charge, but we ask that you register to reserve your space. To register, please submit this short online form.